

| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total Revenue | 40.40 | 5.48 | 0 |
| Total Expenses | 27.63 | 3.21 | 0.01 |
| Profit Before Tax | 12.77 | 2.27 | -0.01 |
| Profit After Tax | 9.50 | 1.71 | -0.01 |
| Operating Profit After Depreciation | 13.41 | 2.34 | -0.01 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Fixed Assets | 31.01 | 13.64 | - |
| Total Non Current Assets | 33.51 | 13.80 | 2.71 |
| Total Current Assets | 21.84 | 6.73 | 1.15 |
| Total Assets | 55.34 | 20.53 | 3.87 |
| Total Shareholder's Fund | 25.94 | 10.80 | 0.37 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Net Cash From Operating Activities | 13.61 | 1.21 | - |
| Net Cash Used In Investing Activities | -18.14 | 0.22 | - |
| Net Cash Used In Financing Activities | 6.16 | -0.47 | - |
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 |
|---|---|---|
| Total Revenue | 5.68 | 0 |
| Total Expenses | 3.74 | 0.01 |
| Profit Before Tax | 1.94 | -0.01 |
| Profit After Tax | 1.45 | -0.01 |
| Operating Profit After Depreciation | 1.98 | -0.01 |
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 |
|---|---|---|
| Fixed Assets | 9.74 | 2.67 |
| Total Non Current Assets | 10.01 | 2.72 |
| Total Current Assets | 6.81 | 1.15 |
| Total Assets | 16.82 | 3.87 |
| Total Shareholder's Fund | 10.89 | 0.37 |
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 |
|---|---|---|
| Net Cash From Operating Activities | -2.11 | - |
| Net Cash Used In Investing Activities | -7.35 | - |
| Net Cash Used In Financing Activities | 10.63 | - |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 30.58 | 23.25 | 12.93 | 15.26 | 9.78 |
| Total Expenses | 24.28 | 16.35 | 7.81 | 6.64 | 7.17 |
| Profit Before Tax | 4.68 | 5.03 | 4.03 | 7.49 | 1.60 |
| Profit After Tax | 4.83 | 3.71 | 2.88 | 5.40 | 1.33 |
| Operating Profit after Depreciation | 7.01 | 6.96 | 5.21 | 8.63 | 2.66 |
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 9.24 | 9.76 | 9.64 | 11.45 | 8.02 |
| Total Expenses | 7.67 | 5.62 | 5.55 | 5.12 | 5.71 |
| Profit Before Tax | 0.85 | 3.16 | 3.13 | 5.40 | 1.48 |
| Profit After Tax | 1.37 | 2.33 | 2.30 | 3.90 | 1.26 |
| Operating Profit after Depreciation | 2.02 | 4.17 | 4.11 | 6.33 | 2.35 |
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Apollo Hospitals Enterprise Ltd | ₹8,495.95 | ₹1,22,158.73 |
| Max Healthcare Institute Ltd | ₹1,008.95 | ₹98,195.43 |
| Fortis Healthcare Ltd | ₹988.95 | ₹74,661.59 |
| Aster DM Healthcare Ltd | ₹814.20 | ₹42,185.41 |
| Narayana Hrudayalaya Ltd | ₹1,861.80 | ₹38,047.89 |
| Fund Name | AUM |
|---|---|
| Bandhan BSE Healthcare Index Fund | 0.01% |
On 28 May 2026
25 May 2026, 05:26 pm
To 14 February 2026
12 Feb 2026, 11:16 am
On 13 February 2026
11 Feb 2026, 11:33 am
Shares of Gujarat Kidney and Super Speciality were currently trading at Rs 115.25 at 10:20 IST on the BSE, representing a premium of 1.10% as compared with the issue price of Rs 114.
30 Dec 2025, 10:26 am

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.